Publications by authors named "Michel Melac"

Claim this Profile
S
Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study.
Margitta Worm, Sabina Rak, Frédéric de Blay, Hans-Jorgen Malling, Michel Melac

Clin Transl Allergy· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
Linda S Cox, Thomas B Casale, Anjuli S Nayak, David I Bernstein, Peter S Creticos, Michel Melac

J Allergy Clin Immunol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
Alain Didier, Margitta Worm, Friedrich Horak, Gordon Sussman, Olivier de Beaumont, Michel Melac

J Allergy Clin Immunol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents.
Susanne Halken, Lone Agertoft, Jürgen Seidenberg, Carl-Peter Bauer, François Payot, Michel Melac

Pediatr Allergy Immunol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
Friedrich Horak, Petra Zieglmayer, René Zieglmayer, Patrick Lemell, Philippe Devillier

J Allergy Clin Immunol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Gabrielle Pauli, Tina H Larsen, Sabina Rak, Friedrich Horak, Elide Pastorello, Michel Melac

J Allergy Clin Immunol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Alain Didier, Hans-Jörgen Malling, Margitta Worm, Friedrich Horak, Siegfried Jäger, Michel Melac

J Allergy Clin Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
Ashok Purohit, Michel Melac, Gabrielle Pauli, Nelly Frossard

Ann Allergy Asthma Immunol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin.
Ashok Purohit, Michel Melac, Gabrielle Pauli, Nelly Frossard

Br J Clin Pharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis